Literature DB >> 861067

Cellular infiltrates in scleroderma skin.

R Fleischmajer, J S Perlish, J R Reeves.   

Abstract

The purpose of this study was to determine the frequency, distribution, and nature of cellular infiltrates in 108 skin biopsies from patients with systemic scleroderma (SS) and localized scleroderma (LS). Cellular infiltrates, perivascular or diffuse, were noted in 49% of SS and 84% of LS patients and consisted of lymphocytes, plasma cells, and macrophages. No correlation was noted between the presence or severity of skin cellular infiltrates and serum serologic abnormalities.

Entities:  

Mesh：

Year:  1977        PMID： 861067     DOI： 10.1002/art.1780200410

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


  76 in total

Review 1.  T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

Authors:  C Chizzolini
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Effects of immunomodulating therapy in systemic sclerosis.

Authors:  F H van den Hoogen; A M Boerbooms; L B van de Putte
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

3.  Peripheral T lymphocytes from patients with early systemic sclerosis co-cultured with autologous fibroblasts undergo an oligoclonal expansion similar to that occurring in the skin.

Authors:  Raffaele De Palma; Francesco Del Galdo; Salvatore Lupoli; Paolo Altucci; Gianfranco Abbate; Gabriele Valentini
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

Review 4.  The endothelium: its role in scleroderma.

Authors:  J D Pearson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

5.  Shiny white patches of the arms and forehead.

Authors:  Jason Emer; Dean David George; Sebastian Bernardo; Harleen Sidhu
Journal:  J Clin Aesthet Dermatol       Date:  2013-08

Review 6.  The role of the acquired immune response in systemic sclerosis.

Authors:  Carlo Chizzolini; Francesco Boin
Journal:  Semin Immunopathol       Date:  2015-07-08       Impact factor: 9.623

Review 7.  The use of Doppler ultrasound to evaluate lesions of localized scleroderma.

Authors:  Suzanne C Li; Melissa S Liebling
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

8.  A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.

Authors:  Arnold E Postlethwaite; Weng Kee Wong; Philip Clements; Soumya Chatterjee; Barri J Fessler; Andrew H Kang; Joseph Korn; Maureen Mayes; Peter A Merkel; Jerry A Molitor; Larry Moreland; Naomi Rothfield; Robert W Simms; Edwin A Smith; Robert Spiera; Virginia Steen; Kenneth Warrington; Barbara White; Frederick Wigley; Daniel E Furst
Journal:  Arthritis Rheum       Date:  2008-06

9.  Expression of ectopeptidases in scleroderma.

Authors:  G Bou-Gharios; J Osman; A Atherton; P Monoghan; R Vancheeswaran; C Black; I Olsen
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

10.  Scleroderma fibroblasts promote migration of mononuclear leucocytes across endothelial cell monolayers.

Authors:  C P Denton; X Shi-Wen; A Sutton; D J Abraham; C M Black; J D Pearson
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.